health
Dr Reddy's, Takeda Ink Deal to Launch Dengue Vaccine QDENGA in India's Private Market in 2027
Hyderabad: Dr Reddy's Laboratories and Takeda Pharmaceutical Company have entered into an exclusive collaboration to promote and distribute QDENGA, Takeda's dengue vaccine, in India's private...
The partnership will cover both paediatric and adult vaccination. Subject to the completion of applicable processes with local authorities, the vaccine is expected to become available in India during the first half of 2027.
QDENGA received marketing ... [3173 chars]
Read Full ArticleShare this story
Up next
Related Stories
Childhood Obesity: How Can It Be Avoided?
Newswise
WHO Reports Latest Global Trends in Cholera, Meningitis and Plague
The Indian Practitioner
Can Infections Cause Cancer? Lancet Study Links 1 In 8 Cancer Cases To Viruses
NDTV
India has PET-CT machines-So why are cancer patients still waiting for reports?
theweek.in
Decaf helps the memory, and caffeine eases anxiety: Coffee study
ThePrint